Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.1137
S.1137: Medical Innovation Prize Fund Act
About This Bill
- This bill was introduced in the 112th Congress
- This bill is primarily about health
- Introduced May 26, 2011
- Latest Major Action May 15, 2012
- See the three similar bills introduced in other congresses.
Bill Sponsor
Bill Summary
Medical Innovation Prize Fund Act - Prohibits any person from having the right to exclusively manufacture, distribute, sell, or use in interstate commerce a drug, a biological product, or a drug or biological product manufacturing process, including the exclusive right to rely on health registration data or the 30-month stay-of-effectiveness period for Orange Book patents, notwithstanding provisions of U.S. patent law and other relevant...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
|
Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Aging. Hearings held. With printed Hearing: S.Hrg. 112-570.
|
|
May 26, 2011 |
Introduced in the Senate by Bernard Sanders (ID-Vt.) |